CRO V-Ensure raises Rs.130-Cr from Investcorp, Tanas Capital

Mumbai-based contract research and manufacturing organisation V-Ensure Pharma Technologies has raised INR 130 crore (approx USD 17.5 million) from alternative investment firm Investcorp, with participation from Asia-based private investment firm Tanas Capital. This marks Investcorp's third healthcare investment in India and its first in the pharmaceutical sector. The investment will help V-Ensure pursue growth opportunities across North America, Europe and other global markets. Founded in 2010, V-Ensure develops specialty pharmaceutical formulations focused on complex generics for regulated markets.